Focussing on advantages of the lab2lab system in the drug discovery industry, Brian Everett, Investigator III, Novartis, will present ‘A virtual analytical instrument in every laboratory’ on Sunday 11th March at 3:35pm in session 10. This will describe lab2lab’s novel approach to submitting and transporting samples for analysis across an entire site, detailing typical throughput capabilities and time savings.
For more information on chipCAL, aequus and lab2lab, visit TTP Labtech at booth #3470 at Pittcon, or go to http://www.ttplabtech.com/
# # #
Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy. We are experts in lead generation, and our sound marketing and sales experience in our sectors has been the backbone of Alto’s success.




